Senior Principal Statistical Programmer - SAS & R (Remote)

Placements24; Upington; Remote; ZAR 2,329,000 - 3,161,000; Full time

Job summary

Cytel Inc. is recruiting a Senior/Principal Statistical Programmer for a remote role embedded with a pharmaceutical client. You will lead SAS and R programming for SDTM/ADaM, review and define data specifications, and oversee CRO deliverables to meet timelines.

The role requires strong regulatory submission experience, independence, and leadership. You will collaborate with biostatistics and programming teams to ensure high-quality data outputs and adherence to FDA/ICH guidelines in a global,

Qualifications

• Minimum bachelor’s degree in computer science, data science, mathematics, or statistics.
• 7+ years as Statistical Programmer in Biotech/Pharma Clinical Development or similar team.
• Exceptional SAS programming skills and CDISC standards experience.
• Experience with regulatory submissions and FDA/ICH regulations.

Responsibilities

• Generate SDTM and ADaM specs, datasets, and define.xml for multiple studies.
• Develop SAS programs for datasets, listings, tables, and graphs.
• Deliver high-quality SAS/R programs for clinical development needs.
• Oversee CRO programming deliverables and ensure timelines.
• Support clinical study reports, regulatory submissions, and DSURs.

Skills

SAS programming

R programming

CDISC standards

Regulatory submissions

Independent working

Leadership

Education

Bachelor's degree in CS/Data Science/Math/Statistics

Tools

SAS

R

Python

Java

Git

Unix/Linux

Shiny

Job description

Cytel Inc. is recruiting a Senior/Principal Statistical Programmer for a remote role embedded with a pharmaceutical client. You will lead SAS and R programming for SDTM/ADaM, review and define data specifications, and oversee CRO deliverables to meet timelines.

The role requires strong regulatory submission experience, independence, and leadership. You will collaborate with biostatistics and programming teams to ensure high-quality data outputs and adherence to FDA/ICH guidelines in a global,